Be The Match BioTherapies® and Atara Biotherapeutics Announce Multi-Year Partnership Extension

Author's Avatar
Jan 06, 2022

Be The Match BioTherapies and Atara Biotherapeutics, Inc. (Nasdaq: ATRA), today announced an extension of their collaboration to provide high-quality healthy donor cells for Atara’s off-the-shelf T-cell immunotherapy platform for patients with cancer and autoimmune diseases.